MCID: URM002
MIFTS: 48

Uremia malady

Category: Nephrological diseases

Aliases & Classifications for Uremia

About this section

Aliases & Descriptions for Uremia:

Name: Uremia 11 50 39 13 68
 
Uremia of Renal Origin 11

Classifications:



External Ids:

Disease Ontology11 DOID:4676
ICD1030 N19
MeSH39 D014511

Summaries for Uremia

About this section
Wikipedia:71 Uremia is the condition of having \"urea in the blood\". Urea is one of the primary components of urine.... more...

MalaCards based summary: Uremia, also known as uremia of renal origin, is related to pericarditis and myocardial infarction. An important gene associated with Uremia is EPO (Erythropoietin), and among its related pathways are Vitamin D Metabolism and Osteoblast Signaling. The drugs charcoal and charcoal,activated pwdr have been mentioned in the context of this disorder. Affiliated tissues include kidney, testes and endothelial, and related mouse phenotypes are limbs/digits/tail and integument.

Related Diseases for Uremia

About this section

Diseases related to Uremia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 172)
idRelated DiseaseScoreTop Affiliating Genes
1pericarditis29.0ALB, CRP, LPL, RETN, TNFRSF11B, VWF
2myocardial infarction28.4ALB, APOC3, CRP, RETN, VWF
3vitiligo mental retardation facial dysmorphism uremia11.8
4nephronophthisis11.1
5nephronophthisis 1, juvenile10.9
6hemolytic-uremic syndrome10.8
7euthyroid sick syndrome10.8
8autosomal dominant medullary cystic kidney disease with hyperuricemia10.8
9autosomal dominant medullary cystic kidney disease without hyperuricemia10.8
10gilles de la tourette syndrome10.3ALB, B2M
11stickler syndrome10.3PTH, TNFRSF11B
12striatonigral degeneration10.2ALB, CASR, PTH
13plummer's disease10.2ALB, B2M, CRP
14breast metaplastic carcinoma10.2B2M, EPO, PTH
15intra-abdominal lymph node mast cell malignancy10.2CRP, SPP1, TNFRSF11B
16mitochondrial dna depletion syndrome 610.2CASR, SPP1, VDR
17ischemic optic neuropathy10.2ALB, CRP, VWF
18waardenburg syndrome, type 4b10.2CASR, PTH, VDR
19anterior foramen magnum meningioma10.2ALB, B2M, EPO
20gastric antral vascular ectasia10.2CASR, PTH, VDR
21shoulder impingement syndrome10.2ALB, CRP
22hyperlipoproteinemia type iv10.2ALB, CRP, LEP
23acrorenal syndrome10.2PTH, TNFRSF11B, VDR
24deafness, autosomal recessive 7910.2CRP, SPP1, VWF
25y chromosome detection10.2PTH, VDR
26weill-marchesani syndrome10.2CASR, PTH, VDR
27opioid abuse10.2CASR, PTH, VDR
28pre-eclampsia10.2CASR, PTH, VDR
29indian tick typhus10.2CASR, PTH, VDR
30sclerosing adenosis of breast10.2ALB, B2M, CRP
31parathyroid carcinoma10.2CASR, PTH, VDR
32cerebral sarcoidosis10.2ALB, EPO, TF
33poems syndrome10.2CRP, EPO, TF
34congenital chloride diarrhea10.2ALB, CRP, VWF
35ischemic bone disease10.1PTH, TNFRSF11B, VDR
36spastic entropion10.1ALB, CRP, TF
37cranial nerve palsy10.1B2M, CRP, TNFRSF11B
38blind hypotensive eye10.1CRP, EPO, TF
39atherosclerosis10.1
40malignant hyperthermia susceptibility 110.1ALB, B2M, TF
41ceroid lipofuscinosis, neuronal, kufs type, adult onset10.1CRP, SPP1, TNFRSF11B, VWF
42dysbaric osteonecrosis10.1PTH, SPP1, TNFRSF11B, VDR
43acrocephalopolydactyly10.1LEP, RETN
44tinea unguium10.1CASR, PTH, TNFRSF11B, VDR
45bladder papillary transitional cell neoplasm10.1B2M, PTH, TNFRSF11B
46hyperparathyroidism10.1
47newborn respiratory distress syndrome10.1CASR, SPP1, VDR
48retinal arterial macroaneurysm with supravalvular pulmonic stenosis10.1ALB, CRP, EPO, TF
49bladder sarcoma10.1ALB, LEP, TF
50neuronal ceroid-lipofuscinoses10.1ALB, CRP, EPO, TF

Graphical network of the top 20 diseases related to Uremia:



Diseases related to uremia

Symptoms & Phenotypes for Uremia

About this section

MGI Mouse Phenotypes related to Uremia according to GeneCards Suite gene sharing:

41 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053719.0AHSG, EPO, GHR, LEP, PTH, TNFRSF11B
2MP:00107718.6B2M, CASR, EPO, GHR, LEP, LPL
3MP:00053708.3ALB, B2M, EPO, GHR, LEP, LPL
4MP:00053698.0AHSG, ALB, CASR, EPO, GHR, LEP
5MP:00053977.9B2M, CASR, EPO, GHR, LEP, PTH
6MP:00053847.8ALB, B2M, CASR, EPO, GHR, LEP
7MP:00053857.7B2M, CRP, EPO, GHR, LEP, LPL
8MP:00053907.6AHSG, CASR, EPO, GHR, LEP, PTH
9MP:00053877.5B2M, CASR, CRP, EPO, GHR, LEP
10MP:00053787.3AHSG, B2M, CASR, GHR, LEP, LPL
11MP:00107687.0ALB, B2M, CASR, EPO, GHR, LEP
12MP:00053766.0AHSG, ALB, B2M, CASR, CRP, EPO

Drugs & Therapeutics for Uremia

About this section

Drugs for Uremia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 166)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Histamineapproved, investigationalPhase 4105075614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-(4-imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
4-imidazoleethylamine
5-Imidazoleethylamine
5-imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminoethylglyoxaline
beta-aminoethylimidazole
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
2
Pregabalinapproved, illicit, investigationalPhase 4361148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
3
FexofenadineapprovedPhase 46383799-24-03348
Synonyms:
159389-12-5
2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid
76815-58-2
83799-24-0
AC1L1FQB
Allegra
Allegra-D 12 Hour
Allegra-D 24 Hour
BRD-A73368467-003-02-8
BSPBio_003521
C06999
C32H39NO4
CHEBI:5050
CHEMBL914
CID3348
Carboxyterfenadine
D07958
DB00950
EU-0100488
F 9427
Fexofenadine
Fexofenadine (INN)
Fexofenadine [INN:BAN]
Fexofenadine hydrochloride
Fexofendine
HSDB 7486
KBio2_002449
 
KBio2_005017
KBio2_007585
KBio3_002742
KBioGR_000807
KBioSS_002456
L000869
LS-28827
Lopac0_000488
MDL 16455
MolPort-002-508-207
NCGC00015453-03
NCGC00015453-06
NCGC00092389-02
NCGC00092389-03
SPBio_001197
STK624102
STOCK6S-26154
Spectrum2_001179
Spectrum3_001921
Spectrum4_000204
Spectrum5_001474
Spectrum_001914
Telfast
Telfast (TN)
Terfenadine acid metabolite
Terfenadine carboxylate
Terfenadine-COOH
Terfenidine carboxylate, MDL 16455
UNII-E6582LOH6V
fexofenadine
4
Gabapentinapproved, investigationalPhase 430360142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
5
GlipizideapprovedPhase 43829094-61-93478
Synonyms:
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
172964-66-8
29094-61-9
29094-66-4
30553_FLUKA
38777-27-4
AC-15789
AC1L1G0Z
AC1Q2OG0
Aldiab
Alphapharm Brand of Glipizide
BIDD:GT0476
BPBio1_000224
BRD-K12219985-001-04-8
BRN 0903495
BSPBio_000202
BSPBio_001349
Bio-0161
Bio1_000074
Bio1_000563
Bio1_001052
Bio2_000069
Bio2_000549
C21H27N5O4S
CAS-29094-61-9
CBiol_001788
CHEBI:239286
CHEMBL1073
CID3478
CP 28,720
CP 28720
CP-28720
CPD000058455
D00335
D005913
DB01067
Digrin
Dipazide
EINECS 249-427-6
EU-0100621
G-117
G117_SIGMA
Glibenese
Glibenese Brand of Glipizide
Glibetin
Glican
Glide
Glidiab
Glidiazinamide
Glipid
Glipizida
Glipizida [INN-Spanish]
Glipizide
Glipizide (USP/INN)
Glipizide Extended-Release Tablets
Glipizide Kenfarma Brand
Glipizide [USAN:BAN:INN]
Glipizidum
Glipizidum [INN-Latin]
Gluco-Rite
Glucolip
Glucotrol
Glucotrol (TN)
Glucotrol XL
Glucotrol XL, Glucotrol, Glipizide
Glucozide
Glupitel
Glupizide
Glyde
Glydiazinamide
Glypidizine
 
HMS1361D11
HMS1568K04
HMS1791D11
HMS1989D11
HMS2089C21
HMS2093J09
I06-0186
I06-1985
IDI1_033819
K 4024
K-4024
K4024
KBio2_000069
KBio2_002637
KBio2_005205
KBio3_000137
KBio3_000138
KBioGR_000069
KBioSS_000069
KS-1068
Kenfarma Brand of Glipizide
LS-159679
Lacer Brand of Glipizide
Lilly Brand of Glipizide
Lopac-G-117
Lopac0_000621
MLS000069386
MLS001148176
Melizide
Metaglip
Mindiab
Minidab
Minidiab
Minodiab
MolPort-002-885-830
MolPort-003-666-685
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
N-{4-[β-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea
NCGC00015462-01
NCGC00015462-02
NCGC00015462-05
NCGC00015462-11
NCGC00016802-01
NCGC00023748-03
NCGC00023748-04
NCGC00023748-05
NCGC00023748-06
NCGC00023748-07
Napizide
Ozidia
Pfizer Brand 1 of Glipizide
Pfizer Brand 2 of Glipizide
Prestwick0_000131
Prestwick1_000131
Prestwick2_000131
Prestwick3_000131
Prestwick_242
S1715_Selelck
S1715_Selleck
SAM002564210
SMR000058455
SPBio_002141
STK631952
Samarium(III) ionophore I
Semiglynase
Sucrazide
TK 1320
TL8006447
UNII-X7WDT95N5C
ZINC00537795
glipizide
nchembio.128-comp32
6
BenzocaineapprovedPhase 420161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
7
MetforminapprovedPhase 41803657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
8
LiraglutideapprovedPhase 4329204656-20-2
Synonyms:
204656-20-2
Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
C439759
Liraglutida
Liraglutida [INN-Spanish]
Liraglutide
Liraglutide [USAN:INN]
Liraglutide recombinant
Liraglutidum
Liraglutidum [INN-Latin]
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
 
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
NN 2211
NN-2211
NN2211
NNC 90-1170
N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide
N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide
UNII-839I73S42A
Victoza
nn 2211
nn2211
victoza
9
PamidronateapprovedPhase 44440391-99-94674
Synonyms:
(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID
(3-Amino-1-hydroxypropylidene)bisphosphonic acid
(3-Amino-1-hydroxypropylidene)diphosphonic acid
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid)
(3-amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate
1-hydroxy-3-aminopropane-1,1-diphosphonic acid
3-Amino-1-hydroxypropylidene-1,1-diphosphonate
40391-99-9
57248-88-1
57248-88-1 (di-hydrochloride salt)
AC1L1IP4
AHPrBP
AKOS003599275
APD
Acide pamidronique
Acide pamidronique [INN-French]
Acido pamidronico
Acido pamidronico [INN-Spanish]
Acidum pamidronicum
Acidum pamidronicum [INN-Latin]
Amidronate
Aminomux
Aredia
BIDD:GT0538
Bisphosphonate 6
C019248
C07395
C3H11NO7P2
 
CHEMBL834
CID4674
ChemDiv1_025240
D07281
DB00282
EINECS 254-905-2
HMS2090C13
HMS658L06
HSCI1_000312
I14-2407
LS-174826
MolPort-002-131-054
NCGC00159433-02
NCGC00159433-03
Novartis brand of pamidronate disodium salt
PAMIDRONATE DISODIUM
PAMIDRONIC ACID
Pamidronate Disodium
Pamidronic acid
Pamidronic acid (INN)
Pamidronic acid [INN:BAN]
Ribodroat
Ribodroat (TN)
STOCK1N-12562
UNII-OYY3447OMC
amino-1-hydroxypropane-1,1-diphosphonate
aminohydroxypropylidene diphosphonate
aminopropanehydroxydiphosphonate
pamidronate
pamidronate calcium
pamidronate monosodium
10
leucovorinapproved, NutraceuticalPhase 4323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
11
Vitamin Eapproved, nutraceutical, vet_approvedPhase 441459-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
12
Vitamin Capproved, nutraceuticalPhase 453150-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
 
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
acide ascorbique
acidum ascorbicum
acidum ascorbinicum
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
ácido ascórbico
13tannic acidapproved, NutraceuticalPhase 42016
14
Folic Acidapproved, nutraceutical, vet_approvedPhase 4439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
15Hormone AntagonistsPhase 4, Phase 213180
16AnalgesicsPhase 4, Phase 311733
17HormonesPhase 4, Phase 214415
18Pharmaceutical SolutionsPhase 4, Phase 3, Phase 28192
19Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 213168
20Histamine AntagonistsPhase 4961
21Histamine H1 AntagonistsPhase 4791
22Histamine H1 Antagonists, Non-SedatingPhase 4359
23Neurotransmitter AgentsPhase 418340
24Central Nervous System DepressantsPhase 413403
25Calcium, DietaryPhase 45713
26Anti-Anxiety AgentsPhase 41885
27AnticonvulsantsPhase 42695
28Anti-Allergic AgentsPhase 41522
29calcium channel blockersPhase 41985
30Peripheral Nervous System AgentsPhase 4, Phase 323689
31
Histamine PhosphatePhase 4104951-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
32Psychotropic DrugsPhase 46430
33Tranquilizing AgentsPhase 44265
34MicronutrientsPhase 4, Phase 26001
35Vitamin B ComplexPhase 44337
36Polymethyl MethacrylatePhase 443
37IncretinsPhase 41579
38Dialysis SolutionsPhase 4, Phase 3, Phase 2175
39HematinicsPhase 41684
40VitaminsPhase 4, Phase 25282
41Trace ElementsPhase 4, Phase 26001
42TocotrienolsPhase 4410
43AntioxidantsPhase 4, Phase 1, Phase 23050
44Protective AgentsPhase 4, Phase 1, Phase 27443
45Vasodilator AgentsPhase 43543
46TocopherolsPhase 4414
47Hypoglycemic AgentsPhase 4, Phase 25896
48FolateNutraceuticalPhase 44392
49TocopherolNutraceuticalPhase 4414
50TocotrienolNutraceuticalPhase 4410

Interventional clinical trials:

(show top 50)    (show all 95)
idNameStatusNCT IDPhase
1Probiotics Use in the Chronic Peritoneal Dialysis PatientsUnknown statusNCT01076426Phase 4
2Pregabalin for the Treatment of Uremic PruritusUnknown statusNCT01852318Phase 4
3Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular EventsCompletedNCT00317005Phase 4
4Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis PatientsCompletedNCT01356433Phase 4
5Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial KidneyCompletedNCT00442819Phase 4
6Oxidative Stress and Hemodialysis Access FailureCompletedNCT00410449Phase 4
7Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNCT00513630Phase 4
8Heat Disinfection of HD Water Treatment System in Hemodialysis PatientsCompletedNCT01138280Phase 4
9Hannover Dialysis Outcome StudyCompletedNCT00529139Phase 4
10Very Low Protein Diet or Dialysis in Uremic Elderly?CompletedNCT00388648Phase 4
11A Clinical Trial of IntensiVE DialysisCompletedNCT00649298Phase 4
12Osteopenia and Renal Osteodystrophy: Evaluation and ManagementCompletedNCT00108394Phase 4
13Liraglutide Treatment to Patients With Severe Renal InsufficiencyCompletedNCT01394341Phase 4
14STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFECompletedNCT00278057Phase 4
15Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUSRecruitingNCT02574403Phase 4
16Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and TreatmentEnrolling by invitationNCT02614898Phase 4
17Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)Unknown statusNCT01486485Phase 3
18The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia PatientsCompletedNCT02747979Phase 2, Phase 3
19Effects of Convective Therapies in Dialysis PatientsCompletedNCT01583309Phase 3
20Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)CompletedNCT01410916Phase 2, Phase 3
21Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)RecruitingNCT02949128Phase 3
22Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHURecruitingNCT02205541Phase 3
23Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance HemodialysisNot yet recruitingNCT02976688Phase 2, Phase 3
24Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)Not yet recruitingNCT03131219Phase 3
25Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeTerminatedNCT00004465Phase 3
26The Plasma Large-Volume Exchange RCTWithdrawnNCT01433003Phase 3
27Effect of SVF Derived MSC in DCD Renal TransplantationUnknown statusNCT02492490Phase 1, Phase 2
28Clonal Deletion on Living-Relative Donor Kidney TransplantationUnknown statusNCT01408797Phase 1, Phase 2
29Treatment of Uremic Pruritus by Olive-omega 3 OintmentUnknown statusNCT01447693Phase 1, Phase 2
30Safety and Efficacy of BMMNC in Patients With Chronic Renal FailureUnknown statusNCT01876017Phase 1, Phase 2
31Rituximab in Patients With Relapsed or Refractory TTP-HUSUnknown statusNCT00531089Phase 2
32L-Cysteine in Peritoneal DialysisCompletedNCT02050139Phase 2
33Clinical and Biochemical Effects of Multipass HemodialysisCompletedNCT01267760Phase 2
34Omega-3 Fatty Acid Administration in Dialysis PatientsCompletedNCT00655525Phase 2
35Vitamin D, Insulin Resistance and Inflammation in ESRDCompletedNCT00656032Phase 2
36Role of Turmeric on Oxidative Modulation in ESRD PatientsCompletedNCT01906840Phase 1, Phase 2
37Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport SyndromeCompletedNCT00309257Phase 2
38Sevelamer in Proteinuric CKDCompletedNCT01968759Phase 2
39A Study in Patients With End-Stage Renal DiseaseCompletedNCT01200290Phase 2
40The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT01757431Phase 2
41An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeCompletedNCT01194973Phase 2
42An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic SyndromeCompletedNCT01193348Phase 2
43Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844844Phase 2
44Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844545Phase 2
45Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSCompletedNCT00844428Phase 2
46Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT00838513Phase 2
47Induction With SVF Derived MSC in Living-related Kidney TransplantationRecruitingNCT02492308Phase 1, Phase 2
48Modulation of Gut Microbiota in End-stage Renal DiseaseNot yet recruitingNCT02568891Phase 2
49Effect of BM-MSCs in DCD Kidney TransplantationNot yet recruitingNCT02561767Phase 1, Phase 2
50Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2

Search NIH Clinical Center for Uremia

Inferred drug relations via UMLS68/NDF-RT46:

Show with subtypes


Cochrane evidence based reviews: uremia

Genetic Tests for Uremia

About this section

Anatomical Context for Uremia

About this section

MalaCards organs/tissues related to Uremia:

36
Kidney, Testes, Endothelial, Bone, Monocytes, Neutrophil, Heart

Publications for Uremia

About this section

Articles related to Uremia:

(show top 50)    (show all 674)
idTitleAuthorsYear
1
Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease. (28523279)
2017
2
Persistence of Vascular Calcification after Reversal of Uremia. (27939134)
2017
3
Co-Expression Analysis of Blood Cell Genome Expression to Preliminary Investigation of Regulatory Mechanisms in Uremia. (28050009)
2017
4
Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health. (26886110)
2016
5
Lion face in a uremia patient. (28011855)
2016
6
Development of Acute Pericarditis Associated with New-onset Rheumatoid Arthritis in a Diabetic Patient with Renal Impairment: The Elusive Nature of Uremia. (27086811)
2016
7
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. (26590448)
2016
8
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease. (26831434)
2016
9
Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing. (26739890)
2016
10
MRI Findings of Syndrome of Acute Bilateral Symmetrical Basal Ganglia Lesions in Diabetic Uremia: A Case Report and Literature Review. (27493824)
2016
11
Uremia-caused changes of ghrelin system in hippocampus may be associated with impaired cognitive function of hippocampus. (26861060)
2016
12
Effect of 1,25-(OH)2D3 and lipopolysaccharide on mononuclear cell inflammation in type 2 diabetes mellitus and diabetic nephropathy uremia. (27706649)
2016
13
Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem. (26676134)
2016
14
Comparison of HLA-A, -B and -DRB1 Loci Polymorphism between Kidney Transplants of Uremia Patients and Healthy Individuals in Central China. (27780235)
2016
15
Comparing classification performance of several types of significant genes to identify key genes in uremia. (27383319)
2016
16
Ptosis and uremia as a rare feature of uremia. (27728481)
2016
17
Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis. (26765403)
2016
18
A Comparison between Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Eradication in Patients with Uremia: A Randomized Clinical Trial. (26933480)
2016
19
Outcome of End-Stage Renal Disease Patients with Advanced Uremia and Acidemia. (26787028)
2016
20
Berberine Reduces Uremia-associated Intestinal Mucosal Barrier Damage. (27506986)
2016
21
DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation. (27018948)
2016
22
Urea transporters and sweat response to uremia. (27273880)
2016
23
Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis. (27992874)
2016
24
Inhibiting post-translational core fucosylation prevents vascular calcification in the model of uremia. (27521658)
2016
25
Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. (26988587)
2016
26
Effectiveness of posthemodialysis administration of pregabalin (75 mg) in treatment resistance uremia pruritus. (26957874)
2016
27
Uremia-Associated Premature Ageing Of T Cells Does Not Predict Infectious Complications After Renal Transplantation. (26914971)
2016
28
Myocardial bioenergetic abnormalities in experimental uremia. (27307758)
2016
29
Sweating in Systemic Abnormalities: Uremia and Diabetes Mellitus. (27584963)
2016
30
An empirical study of a hybrid imbalanced-class DT-RST classification procedure to elucidate therapeutic effects in uremia patients. (27053166)
2016
31
Posterior Reversible Encephalopathy Syndrome in a Patient with Severe Uremia without Hypertension. (26726088)
2016
32
Study on 3'-UTR length polymorphism in peripheral blood mononuclear cells of uremia patient. (26554293)
2015
33
Pseudotumor cerebri associated with uremia and NSAIDs. (26022039)
2015
34
Anti-inflammatory effects of 1,25-dihydroxyvitaminA D3A in monocytes cultured in serum from patients with typeA 2 diabetes mellitus and diabetic nephropathy with uremia via Toll-like receptorA 4 and nuclear factor-I_B p65. (26497229)
2015
35
Altered Renal Expression of Relevant Clinical Drug Transporters in Different Models of Acute Uremia in Rats. Role of Urea Levels. (26065488)
2015
36
Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia? (25870564)
2015
37
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. (26019318)
2015
38
The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction. (26550224)
2015
39
Chorea due to diabetic hyperglycemia and uremia: distinct clinical and imaging features. (25649292)
2015
40
Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss. (25783847)
2015
41
Macrophages Are Involved in Gut Bacterial Translocation and Reversed by Lactobacillus in Experimental Uremia. (26518418)
2015
42
Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release. (26580207)
2015
43
Clinical trials in uremia-time to reappraise. (25497457)
2015
44
Oral manifestations in chronic uremia patients. (26513593)
2015
45
Effect of Chronic Uremia on the Cell Surface Expression of B7 Family Costimulatory Molecules in an HLA-A2 Transgenic Mouse Model of Chronic Kidney Disease. (26310460)
2015
46
Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia. (26054367)
2015
47
Aging and uremia: Is there cellular and molecular crossover? (25664244)
2015
48
Reverse Left Ventricular Remodeling AfterA Kidney Transplantation: Unraveling the Complex Autointoxication of Uremia. (26483102)
2015
49
The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia. (26311115)
2015
50
Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia. (26176653)
2015

Variations for Uremia

About this section

Expression for genes affiliated with Uremia

About this section
Search GEO for disease gene expression data for Uremia.

Pathways for genes affiliated with Uremia

About this section

GO Terms for genes affiliated with Uremia

About this section

Cellular components related to Uremia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1HFE-transferrin receptor complexGO:199071210.3B2M, TF
2chylomicronGO:00426279.8APOC3, LPL
3platelet alpha granule lumenGO:00310939.8AHSG, ALB, VWF
4endoplasmic reticulum lumenGO:00057889.5AHSG, ALB, B2M, SPP1, TF
5cell surfaceGO:00099869.1B2M, CASR, EPO, GHR, LPL, TF
6very-low-density lipoprotein particleGO:00343619.0APOC3, LPL
7extracellular exosomeGO:00700626.9AHSG, ALB, APOC3, B2M, CRP, LPL
8extracellular spaceGO:00056155.4AHSG, ALB, APOC3, B2M, CRP, EPO
9extracellular regionGO:00055765.3AHSG, ALB, APOC3, B2M, CRP, EPO

Biological processes related to Uremia according to GeneCards Suite gene sharing:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1response to fibroblast growth factorGO:007177410.6CASR, PTH
2positive regulation of tyrosine phosphorylation of Stat5 proteinGO:004252310.6EPO, GHR
3intestinal absorptionGO:005089210.5LEP, VDR
4negative regulation of lipid storageGO:001088810.5CRP, LEP
5cellular response to iron ionGO:007128110.5B2M, TF
6iron ion transportGO:000682610.5B2M, TF
7response to vitamin DGO:003328010.5PTH, SPP1
8positive regulation of receptor-mediated endocytosisGO:004826010.5B2M, TF
9cellular calcium ion homeostasisGO:000687410.5CASR, PTH, VDR
10positive regulation of JAK-STAT cascadeGO:004642710.4GHR, LEP
11acute-phase responseGO:000695310.2AHSG, CRP, EPO
12high-density lipoprotein particle remodelingGO:003437510.1ALB, APOC3
13response to nutrientGO:000758410.1EPO, LEP, TNFRSF11B
14retina homeostasisGO:000189510.1ALB, B2M, TF
15chylomicron remodelingGO:00343719.7APOC3, LPL
16response to drugGO:00424939.7B2M, LPL, PTH, TNFRSF11B
17platelet degranulationGO:00025769.7AHSG, ALB, TF, VWF
18post-translational protein modificationGO:00436879.6AHSG, ALB, SPP1, TF
19lipoprotein metabolic processGO:00421579.5ALB, APOC3, LPL
20cellular protein metabolic processGO:00442679.4AHSG, ALB, B2M, SPP1, TF
21skeletal system developmentGO:00015019.1AHSG, PTH, TNFRSF11B, VDR

Molecular functions related to Uremia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide hormone receptor bindingGO:00514289.8LEP, PTH
2hormone activityGO:00051799.3EPO, LEP, PTH, RETN

Sources for Uremia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet